FDA
Chou2 Pharma launches clinical trials with Penn Vet’s Veterinary Clinical Investigations Center
Study will focus on effects of CBD and CBG for canine elbow osteoarthritis
$8 million for FDA’s Center for Veterinary Medicine in spending package passed by House
Funding intended to improve the animal food ingredient review and approval process as well as developing regulations for ingredient claims
New sedative for dogs is launched
Dechra’s alpha-2 combination drug is indicated to minimize stress surrounding canine sedation
FDA grants conditional approval for drug delaying start of congestive heart failure in canines
This chewable tablet is the first drug on the market for delaying the onset of Stage B2 preclinical myxomatous mitral valve disease in canines
FDA accepting 2023 grant applications for animal drugs for minor uses and minor species
Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.
New antibiotic for cattle and swine is available
Tulathromycin injection is an option for bovine respiratory disease, and other conditions